Literature DB >> 15191368

Pathological study on the relationship between C4d, CD59 and C5b-9 in acute renal allograft rejection.

S Nishi1, N Imai, Y Ito, M Ueno, S Fukase, H Mori, M Arakawa, A Bassam, K Saito, K Takahashi, F Gejyo.   

Abstract

In order to evaluate the activation or inhibition of the later phases of classical complement cascade in renal allograft presenting with acute rejection, particularly with C4d deposition on the peritubular capillary (PTC), we observed the expression of CD59 and C5b-9 on the PTC. Subjective cases were divided into two groups, an acute rejection group, of 4 males and 6 females, and a normal donor group, of 5 males and 5 females. Renal biopsies were performed at the onset of acute rejection and at the transplant operation, before reperfusion. C4d deposition on PTC was found in three of 10 cases (30%) with biopsy proven acute rejection, whereas CD59 on PTC was positively expressed in all of the rejection cases. Although C5b-9 was not observed on PTC in the acute rejection group, it was intensively deposited on the tubular basement membrane (TBM) in five cases, including the three with positive C4d on PTC. In the normal donor group, CD59 on PTC was intensively observed, whereas C5b-9 was weakly expressed on TBM. CD59, a complement regulatory factor, works as an inhibitory factor against the formation of C5b-9, a membrane attack complex. From our data, we noted the dissociation between the depositions of C4d and C5b-9 on PTC. The substantially expressed CD59 on PTC may affect this dissociation between C4d and C5b-9 on PTC. The intensive deposition of C5b-9 on TBM in acute rejection cases may suggest an independent immunological injury attacking tubular cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191368     DOI: 10.1111/j.1399-0012.2004.00242

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  4 in total

Review 1.  Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.

Authors:  Jacob J E Koopman; Mieke F van Essen; Helmut G Rennke; Aiko P J de Vries; Cees van Kooten
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

2.  Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney.

Authors:  Gesa Tiller; Rosa G M Lammerts; Jessy J Karijosemito; Firas F Alkaff; Arjan Diepstra; Robert A Pol; Anita H Meter-Arkema; Marc A Seelen; Marius C van den Heuvel; Bouke G Hepkema; Mohamed R Daha; Jacob van den Born; Stefan P Berger
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

3.  Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes?

Authors:  James C Cicciarelli; Nathan A Lemp; Youngil Chang; Michael Koss; Katrin Hacke; Noriyuki Kasahara; Kevin M Burns; David I Min; Robert Naraghi; Tariq Shah
Journal:  J Immunol Res       Date:  2017-01-15       Impact factor: 4.818

4.  Molecular Assessment of C4d-Positive Renal Transplant Biopsies Without Evidence of Rejection.

Authors:  Katherine M Dominy; Michelle Willicombe; Tariq Al Johani; Hannah Beckwith; Dawn Goodall; Paul Brookes; H Terence Cook; Tom Cairns; Adam McLean; Candice Roufosse
Journal:  Kidney Int Rep       Date:  2018-09-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.